Personalized choice of maintenance therapies in non-small-cell lung cancer

Por Blais, N., Corrales–Rodriguez, L.
Publicado em 2012

Management of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitors

Por Hirsh, V., Blais, N., Burkes, R., Verma, S., Croitoru, K.
Publicado no Curr Oncol (2014)

Factors influencing treatment selection and survival in advanced lung cancer

Por Tabchi, S., Kassouf, E., Florescu, M., Tehfe, M., Blais, N.
Publicado no Curr Oncol (2017)

Clinical challenges in patients with cancer-associated thrombosis: Canadian expert consensus recommendations

Por Carrier, M., Lazo–Langner, A., Shivakumar, S., Tagalakis, V., Gross, P.L., Blais, N., Butts, C.A., Crowther, M.
Publicado no Curr Oncol (2015)

Standardizing biomarker testing for Canadian patients with advanced lung cancer

Por Melosky, B., Blais, N., Cheema, P., Couture, C., Juergens, R., Kamel-Reid, S., Tsao, M.-S., Wheatley-Price, P., Xu, Z., Ionescu, D.N.
Publicado no Curr Oncol (2018)

Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea

Por Maroun, J.A., Anthony, L.B., Blais, N., Burkes, R., Dowden, S.D., Dranitsaris, G., Samson, B., Shah, A., Thirlwell, M.P., Vincent, M.D., Wong, R.
Publicado em 2007

A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer

Por Chiappori, A. A., Kolevska, T., Spigel, D. R., Hager, S., Rarick, M., Gadgeel, S., Blais, N., Von Pawel, J., Hart, L., Reck, M., Bassett, E., Burington, B., Schiller, J. H.
Publicado no Ann Oncol (2015)

A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small c...

Por Chow, L. Q. M., Blais, N., Jonker, D. J., Laurie, S. A., Diab, S. G., Canil, C., McWilliam, M., Thall, A., Ruiz-Garcia, A., Zhang, K., Tye, L., Chao, R. C., Camidge, D. R.
Publicado em 2011

Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancer

Por Melosky, B., Agulnik, J., Albadine, R., Banerji, S., Bebb, D.G., Bethune, D., Blais, N., Butts, C., Cheema, P., Cheung, P., Cohen, V., Deschenes, J., Ionescu, D.N., Juergens, R., Kamel-Reid, S., Laurie, S.A., Liu, G., Morzycki, W., Tsao, M.S., Xu, Z., Hirsh, V.
Publicado no Curr Oncol (2016)

Management of Kidney Cancer: Canadian Kidney Cancer Forum Consensus Update 2011: Canadian Kidney Cancer Forum 2011

Por Jewett, MAS, Finelli, A, Kollmannsberger, C, Wood, L, Legere, L, Basiuk, J, Canil, C, Heng, D, Reaume, N, Tanguay, S, Atkins, M, Bjarnason, G, Dancey, J, Evans, M, Fleshner, N, Haider, M, Kapoor, A, Uzzo, R, Maskens, D, Soulieres, D, Yousef, G, Basappa, N, Bendali, N, Black, P, Blais, N, Cagiannos, I, Care, M, Chow, R, Chung, H, Czaykowski, P, DeRosa, D, Durrant, K, Ellard, S, Farquharson, G, Filion-Brulotte, C, Gingerich, J, Godbout, L, Grant, R, Hamilton, W, Kassouf, W, Kurban, G, Lane, K, Lattouf, JB, Lau, D, Leveridge, M, McCarthy, J, Moore, R, North, S, O’Brien, P, Pituskin, E, Racine, P, Rendon, R, So, A, Sridhar, S, Stubbs, K, Su, Z, Taylor, L, Udall, T, Venner, P, Vogel, W, Yap, S, Yau, P, Cooper, M, Giroux, N, Miron, D, Mosher, D, Ross, K, Willacy, J
Publicado em 2012